CStone Pharmaceuticals
HKEX:2616

Watchlist Manager
CStone Pharmaceuticals Logo
CStone Pharmaceuticals
HKEX:2616
Watchlist
Price: 5.57 HKD -1.76% Market Closed
Market Cap: 8.2B HKD

CStone Pharmaceuticals
Investor Relations

Cstone Pharmaceuticals Co. Ltd. engages in the research and development of highly complex biopharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 264 full-time employees. The company went IPO on 2019-02-26. Through its subsidiaries, the Company is primarily engaged in development, manufacturing and sales of biopharmaceutical products. Its main products include immuno-oncology drugs and molecularly targeted drugs. The firm conducts its businesses mainly in domestic market.

Show more
Loading
2616
Hang Seng (Hong Kong)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Jianxin Yang M.D., Ph.D.
CEO, President of R&D and Executive Director
No Bio Available
Ms. Weicong Ni
CFO & Joint Company Secretary
No Bio Available
Ms. Ying Hua Zhang
Senior VP & Chief Operating Officer
No Bio Available
Dr. Ngai Chiu Tse M.D., Ph.D.
Senior VP & Chief Scientific Officer
No Bio Available
Mr. Michael J. Choi M.B.A.
Chief Commercial & Strategic Officer
No Bio Available
Dr. Yujuan La
Senior Vice President of Product Development
No Bio Available
Ms. Mei Yee Yung FCIS, FCS
Joint Company Secretary
No Bio Available

Contacts

Address
SHANGHAI
Shanghai
11th Floor, Qiushi Building, No. 383 Guangyan Road, Jing'an District
Contacts